These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21103798)

  • 1. Treatment with nasal neuro-EPO improves the neurological, cognitive, and histological state in a gerbil model of focal ischemia.
    Rodríguez Cruz Y; Mengana Támos Y; Muñoz Cernuda A; Subirós Martines N; González-Quevedo A; Sosa Testé I; García Rodríguez JC
    ScientificWorldJournal; 2010 Nov; 10():2288-300. PubMed ID: 21103798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonhematopoietic variants of erythropoietin in ischemic stroke: need for step-wise proof-of-concept studies.
    Hermann DM
    ScientificWorldJournal; 2010 Nov; 10():2285-7. PubMed ID: 21103797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose effect evaluation and therapeutic window of the neuro-EPO nasal application for the treatment of the focal ischemia model in the Mongolian gerbil.
    Teste IS; Tamos YM; Cruz YR; Cernada AM; Rodríguez JC; Martínez NS; Antich RM; González-Quevedo A; Rodríguez JC
    ScientificWorldJournal; 2012; 2012():607498. PubMed ID: 22701364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different expression patterns of Ngb and EPOR in the cerebral cortex and hippocampus revealed distinctive therapeutic effects of intranasal delivery of Neuro-EPO for ischemic insults to the gerbil brain.
    Gao Y; Mengana Y; Cruz YR; Muñoz A; Testé IS; García JD; Wu Y; Rodríguez JC; Zhang C
    J Histochem Cytochem; 2011 Feb; 59(2):214-27. PubMed ID: 21339183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal neuro EPO could be a reliable choice for neuroprotective stroke treatment.
    Parra AL; Rodriguez JC
    Cent Nerv Syst Agents Med Chem; 2012 Mar; 12(1):60-8. PubMed ID: 22376076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nasal route as a potential pathway for delivery of erythropoietin in the treatment of acute ischemic stroke in humans.
    Garcia-Rodriguez JC; Sosa-Teste I
    ScientificWorldJournal; 2009 Sep; 9():970-81. PubMed ID: 19768354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ₂₅₋₃₅ non-transgenic mouse model of Alzheimer's disease.
    Maurice T; Mustafa MH; Desrumaux C; Keller E; Naert G; de la C García-Barceló M; Rodríguez Cruz Y; Garcia Rodríguez JC
    J Psychopharmacol; 2013 Nov; 27(11):1044-57. PubMed ID: 23813967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
    Rodríguez Cruz Y; Strehaiano M; Rodríguez Obaya T; García Rodríguez JC; Maurice T
    J Alzheimers Dis; 2017; 55(1):231-248. PubMed ID: 27662300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant erythropoietin without erythropoietic activity is neuroprotective against ischemic brain injury.
    Gan Y; Xing J; Jing Z; Stetler RA; Zhang F; Luo Y; Ji X; Gao Y; Cao G
    Stroke; 2012 Nov; 43(11):3071-7. PubMed ID: 22984011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
    Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
    J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage.
    Yoo SJ; Cho B; Lee D; Son G; Lee YB; Soo Han H; Kim E; Moon C; Moon C
    Cell Death Dis; 2017 Aug; 8(8):e3003. PubMed ID: 28817120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia.
    Yu YP; Xu QQ; Zhang Q; Zhang WP; Zhang LH; Wei EQ
    Neurosci Lett; 2005 Oct; 387(1):5-10. PubMed ID: 16054296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia.
    Wiard RP; Dickerson MC; Beek O; Norton R; Cooper BR
    Stroke; 1995 Mar; 26(3):466-72. PubMed ID: 7886726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity increase in EpoR and Epo expression by intranasal recombinant human erythropoietin (rhEpo) administration in ischemic hippocampi of adult rats.
    Castañeda-Arellano R; Feria-Velasco AI; Rivera-Cervantes MC
    Neurosci Lett; 2014 Nov; 583():16-20. PubMed ID: 25219375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of a nonerythropoietic erythropoietin, Neuro-EPO, in blood after intranasal administration in rat.
    Martin L; Garcia Rodriguez JC; Audran M; Ericsson M; Maurice T; Marchand A
    Drug Test Anal; 2020 Nov; 12(11-12):1605-1613. PubMed ID: 32856413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asialoerythropoietin attenuates neuronal cell death in the hippocampal CA1 region after transient forebrain ischemia in a gerbil model.
    Yamashita T; Nonoguchi N; Ikemoto T; Miyatake S; Kuroiwa T
    Neurol Res; 2010 Nov; 32(9):957-62. PubMed ID: 20444326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke. Laboratory investigation.
    Fletcher L; Kohli S; Sprague SM; Scranton RA; Lipton SA; Parra A; Jimenez DF; Digicaylioglu M
    J Neurosurg; 2009 Jul; 111(1):164-70. PubMed ID: 19284235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin delivered via intra-arterial infusion reduces endoplasmic reticulum stress in brain microvessels of rats following cerebral ischemia and reperfusion.
    Zhao H; Wang R; Wu X; Liang J; Qi Z; Liu X; Min L; Ji X; Luo Y
    J Neuroimmune Pharmacol; 2015 Mar; 10(1):153-61. PubMed ID: 25626440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A neuroprotective derivative of erythropoietin that is not erythropoietic.
    Doggrell SA
    Expert Opin Investig Drugs; 2004 Nov; 13(11):1517-9. PubMed ID: 15500399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal erythropoietin ameliorates neurological function impairments and neural pathology in mice with chronic alcoholism by regulating autophagy‑related Nrf2 degradation.
    Nie X; Wang W; Wang Q; Zhu D; Song H
    Mol Med Rep; 2019 Feb; 19(2):1139-1149. PubMed ID: 30535439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.